Enantiomeric Determination of Medetomidine in Street Drug Samples (August 2024—February 2025) and Implications for Immunoassay Test Strip Analysis
- 3 September 2025
- journal article
- Published by Wiley in Drug Testing and Analysis
- Vol. 17 (12) , 2347-2353
Abstract
Over the last several years, there has been an influx of α 2 ‐agonists into the street drug supply, beginning with the proliferation of xylazine, a potent veterinary sedative. Since 2023, another sedative, medetomidine, has been widely detected. Medetomidine, broadly, encompasses two enantiomers—dexmedetomidine and levomedetomidine—with the dex enantiomer being pharmacologically active and present in human‐use pharmaceuticals. In this work, we investigate street drug samples containing medetomidine to better understand the enantiomeric makeup in the illicit supply. Liquid chromatography tandem mass spectrometry (LC–MS/MS) was used to analyze 100 drug product or paraphernalia residue samples. All samples were found to contain a racemic mixture of medetomidine. A subset of samples was analyzed by medetomidine immunoassay test strips, where racemic mixtures were not found to negatively affect results. All samples were also qualitatively analyzed using direct analysis in real time mass spectrometry (DART‐MS) to identify commonly co‐occurring compounds, which included fentanyl, xylazine, and local anesthetics. Parabens, preservatives found in licit injectable preparations of the drug, were not detected. This work provides a snapshot into the medetomidine makeup of the street drug supply, which needs to be continually monitored given the differences in pharmacology between the two enantiomers.Keywords
All Related Versions
Funding Information
- National Center for Injury Prevention and Control
- Centers for Disease Control and Prevention
This publication has 14 references indexed in Scilit:
- Medetomidine quantitation and enantiomer differentiation in biological specimens collected after fatal and non-fatal opioid overdosesJournal of Analytical Toxicology, 2025
- Responding to medetomidine: clinical and public health needsThe Lancet Regional Health - Americas, 2025
- Medetomidine Infiltrates the US Illicit Opioid MarketJAMA, 2024
- Classics in Chemical Neuroscience: MedetomidineACS Chemical Neuroscience, 2024
- Fentanyl Test Strips for Harm Reduction: A Scoping ReviewJournal of Addiction Medicine, 2024
- An analytical platform for near real-time drug landscape monitoring using paraphernalia residuesForensic Chemistry, 2023
- Development and validation of a chiral LC‐MS method for the enantiomeric resolution of (+) and (−)‐medetomidine in equine plasma by using polysaccharide‐based chiral stationary phasesChirality, 2020
- Antimicrobial preservative use in parenteral products: Past and presentJournal of Pharmaceutical Sciences, 2007
- Central apnoea after balanced general anaesthesia that included dexmedetomidineBritish Journal of Anaesthesia, 2005
- Resolution of Methamphetamine Stereoisomers in Urine Drug Testing: Urinary Excretion of R(−)-Methamphetamine Following Use of Nasal InhalersJournal of Analytical Toxicology, 1988